CSL PHARMA-ADVICE ApS — Credit Rating and Financial Key Figures

CVR number: 36501693
Birkevej 4, Åvang 4320 Lejre

Income statement (kDKK)

2018
2019
2020
2021
2022
Fiscal period length1212121212
Net sales399.61261.33143.18
External services- 119.07-80.81-48.20-34.6930.60
Gross profit280.54180.5294.98-34.6930.60
EBIT280.54180.5294.98-34.6930.60
Other financial income4.00
Other financial expenses-4.15-3.04-3.14-9.841.89
Pre-tax profit280.39177.4891.83-44.5332.50
Income taxes-66.05-42.90-21.12
Net earnings214.34134.5870.72-44.5332.50

Assets (kDKK)

2018
2019
2020
2021
2022
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables7.4616.7615.623.053.04
Current deferred tax assets7.6910.00
Short term receivables total7.4616.7623.323.0513.04
Cash and bank deposits582.15538.83426.22273.51127.48
Cash and cash equivalents582.15538.83426.22273.51127.48
Balance sheet total (assets)589.61555.60449.54276.56140.52

Equity and liabilities (kDKK)

2018
2019
2020
2021
2022
Share capital50.0050.0050.0050.0050.00
Shares repurchased200.00130.00110.00100.00
Retained earnings81.28165.62190.20160.9151.39
Profit of the financial year214.34134.5870.72-44.5332.50
Shareholders equity total545.62480.20420.91266.39133.89
Non-current liabilities total
Current trade creditors28.6310.176.63
Short-term deferred tax liabilities43.8975.40
Other non-interest bearing current liabilities0.09
Current liabilities total43.9975.4028.6310.176.63
Balance sheet total (liabilities)589.61555.60449.54276.56140.52
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.